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ABSTRACT
A random sequencing strategy applied to two large Sa/I
restriction fragments (SB and SD) of the African swine
fever virus (ASFV) genome revealed that they might
encode proteins similar to the two largest RNA
polymerase subunits of eukaryotes, poxvlruses and
Escherichla coll. After further mapping by dot-blot
hybridization, two large open reading frames (ORFs)
were completely sequenced. The first ORF (NP1450L)
encodes a protein of 1450 amino acids with extensive
similarity to the largest subunlt of RNA polymerases.
The second one (EP1242L) codes for a protein of 1242
amino acids similar to the second largest RNA
polymerase subunlt. Proteins NP1450L and EP1242L
are more similar to the corresponding subunits of
eukaryotic RNA polymerase II than to those of vaccinia
virus, the prototype poxvlrus, which shares many
functional characteristics with ASFV. ORFs NP1450L
and EP1242L are mainly expressed late in ASFV
Infection, after the onset of DNA replication.
INTRODUCTION
Viruses which replicate in the cytoplasm of eukaryotic cells
probably have no access to the host transcriptional machinery.
Two families of large DNA viruses share this cytoplasmic
location: poxviruses, and a yet unnamed group of which African
swine fever virus (ASFV) is the only known member. Poxviruses
overcome this problem by encoding their own enzymes for
transcription and RNA modification. Transcription of vaccinia
virus is carried out by a multimeric RNA polymerase composed
of two large and many small subunits, all of which seem to be
virus encoded (reviewed in (1)). This multisubunit enzyme
resembles the RNA polymerases of eukaryotic cells, and the two
largest and the smallest subunits of vaccinia virus have similar
amino acid sequences to their cellular counterparts (2—4). The
replicative cycle of ASFV, consisting first of a nuclear stage
followed by a longer cytoplasmic phase of DNA replication (5),
is more complex than drat of poxviruses, secluded to the cell
cytoplasm (reviewed in (6)). Both ASFV and vaccinia virus
particles carry a DNA-dependent RNA polymerase which is not
sensitive to a-amanitin (1, 7), a toxin which strongly inhibits
cellular RNA polymerase II (8). The RNA polymerase activities
of ASFV and vaccinia virus particles share a number of properties
regarding substrate requirements and pattern of inhibition by
rifampicin derivatives (7, 9). Moreover, both viruses encode
proteins similar to the eukaryotic transcription factor SII (THIS;
(10, 11)). Taken together, these data suggest that ASFV might
encode an RNA polymerase similar to that of vaccinia virus. The
recent description of the ASFV gene coding for mRNA
guanylyltransferase (12) suggests that the RNA modification
system of ASFV particles (13) could also be virus-encoded, as
previously shown for vaccinia virus (1).
Here we report the identification, sequencing and
transcriptional expression of the genes encoding the putative two
largest RNA polymerase subunits of ASFV. The deduced amino
acid sequences of the two gene products show obvious similarities
to their pox virus, eukaryotic and bacterial counterparts. Because
of considerable conservation of RNA polymerase domains and
critical sites we suggest that the two identified genes correspond
to RNA polymerase subunits of ASFV. This finding strongly
suggests that ASFV transcription is carried out by a multisubunit
virus-encoded RNA polymerase similar to those of vaccinia virus
and eukaryotic cells.
MATERIALS AND METHODS
Plasmid clones
The cloning of different restriction fragments of the BA71V strain
of ASFV in plasmid vectors has been previously described (14).
The basic EcoRI (R) collection was cloned in pBR325 (p5), while
Sail (S) fragments were cloned in pBR322 (p2). See Fig. 1 for
identification of the various DNA fragments described in the next
paragraphs.
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DNA sequencing
Fragments RK and RT (Fig. 1) were frilly sequenced at random
as follows. The plasmid clones p5RK and p5RT were sheared
by sonication, end-repaired with nuclease SI and Klenow
polymerase, and fragments 300—600 bp-long were cloned into
Smal-cxit M13mpl0. Single-stranded DNA from the recombinants
was sequenced by the dideoxynucleotide chain termination
method (15) using the M13 universal primer. The nucleotide
sequence of the left end of fragment RK, and the random
sequencing of fragment RN' have been previously described
(16-18).
To sequence the left end of fragment RE', overlapping
EcoHUPstl and MndlH M13 subclones were generated (see
Fig. 1). These subclones were sequenced with the M13 universal
primer, synthetic oligonucleotides corresponding to internal
sequences and dideoxynucleotide chain terminators (15).
Fragment RY' had not been detected in our previous mapping
of the ASFV genome (19), and it has now been sequenced with
synthetic oligonucleotides in a PsA M13 clone which also overlaps
parts of RK and RE' (Fig. 1). The nucleotide sequence of the
left end of fragment RO, up to the first Xbal site, has been
previously reported (20). To sequence the rest of RO, the entire
fragment was cloned in M13 and sequenced as described for the
RE' subclones.
The contiguity in the viral DNA of all sequences obtained from
subclones sharing only a restriction site was assessed by
sequencing around the corresponding restriction site in an
overlapping clone.
Computer analysis
The fragmentary DNA sequences from the random sequencing
procedure were compiled using programs DBAUTO and
DBUT1L (21). General analyses of DNA and protein sequences
were made with the programs of the UWGCG (22). Searches
against DNA and protein databases were made with programs
TFASTA and FASTA (23). The multiple alignments were
generated with programs PILEUP (22) and Clustal V (24).
Percentages of identity and similarity between proteins in the
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Figure 1. Map position of ORFs NP1450L and EP1242L within the ASFV
genome. ThefcoRIand Sail maps (19) of the BA7IV strain of ASFV are shown.
ORFs are indicated by arrows. The position of the inserts from M13 clones AS22,
AS136, ASl and AS90 is shown. Subfragments cloned in M13 for sequencing
by oligonucleotide walking are also indicated. Only relevant restriction sites are
indicated in the expanded regions.
multiple alignments were calculated with program DISTANCES
(22).
RNA hybridization
Northern blot hybridizations were carried out with total RNA
isolated from cultured cells. Vero cells were mock-infected or
infected with 20 pfu/cell ASFV BA71V for 18 hr. Infections were
also carried out in the presence of 100 /*g/ml cycloheximide or
40 /ig/ml cytosine arabinoside for 7 hr. Total RNA was prepared
as described (25). 15 /tg RNA were separated in denaturing
agarose, blotted onto nylon filters and hybridized with specific
probes according to standard protocols (26). The probe for
NP1450L RNA was the synthetic oligonucleotide 5'-GGTGGTT-
CCCATTCGCGCATCATAGATACC-3', complementary to
nucleotides 130 to 159 of ORF NP1450L. The probe for
EP1242L RNA was the oligonucleotide 5'-GAGTTTACTGC-
AGCGGAGATAAAGCTCAGC-3', complementary to
nucleotides 78 to 107 of the ORF. The oligonucleotides were
end-labeled with 30 /iCi [7-32P]ATP (26).
RESULTS
Sequencing of the genes coding for the two largest RNA
polymerase subunits
A random cloning and sequencing procedure (27) allowed the
mapping of different genes within two large Sail fragments of
the ASFV genome, SB and SD. Briefly, M13 clones bearing
small subfragments of SB and SD were obtained and sequenced
as described under Materials and Methods for fragments RK and
RT. The DNA sequences were translated in all six frames, and
the derived amino acid sequences were compared with a database
containing poxvirus protein sequences, and the NBRF protein
database, using program FASTP (28). A few M13 recombinants
included inserts whose derived amino acid sequences strongly
resembled different regions of the two largest RNA polymerase
subunits of poxviruses and eukaryotic organisms. The inserts
from four such M13 recombinants (AS22 and AS 136 for the
largest subunit, ASl and AS90 for the second largest subunit;
see Fig. 1) were used to map the corresponding ASFV genes
by dot-blot hybridization. The mixed probes for the largest
subunit hybridized with fragment SD, and more specifically, with
the smaller subclones RT and RN'; the mixture of probes for
NP1450L
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Figure 2. Analysis of the expression of ORFs NP1450L and EP1242L by Northern
blot. Total RNA from Vero cells mock-infected (M) or infected in the absence
(L) or the presence of either cycloheximide (Q or cytosine arabinoside (A) was
subjected to RNA hybridization with probes specific for the NP1450L and
EP1242L RNAs. The sizes of molecular mass markers are shown on the right
side. Arrows indicate virus-specific RNAs. The probe for NP1450L RNA shows
also a non-specific hybridization with the 28S ribosomal RNA.
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the second largest subunit recognized fragment SB, and fragment
RK within the former one (data not shown).
Fragments RT, RN' and RK were sequenced as described
under Materials and Methods. An analysis of the open reading
frames (ORFs) encoded within these fragments revealed that two
large genes had been partially sequenced. Comparisons of the
derived amino acid sequences of these gene fragments with the
RNA polymerase subunits of vaccinia virus and eukaryotic
organisms (not shown) revealed that fragments RT and RN'
encode respectively the central and 5' regions of the gene for
the largest subunit, which should be continued in fragment RO.
The right end of RK encodes the 3' half of the gene for the second
largest subunit, which should start within fragment RE'.
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To complete the sequence of the gene coding for the largest
subunit, the nucleotide sequence of fragment RO was determined
by oligonucleotide walking in M13mpl8 clones bearing that
fragment. The complete ORF encoding this subunit is 4350 bp-
long and, according to the nomenclature proposed for ASFV
ORFs (11), k has been called NP1450L (Fig. 1). ORF NP1450L
is tightly packed between the genes coding for the attachment
protein of ASFV to Vero cells (20) and DNA ligase (18), with
spacers less than 100 bp-long. The deduced molecular mass and
isoelectric point of protein NP1450L are 163.8 kDa and 8.8,
respectively.
Overlapping M13 clones bearing the left end of fragment RE'
and fragment RY' (Fig. 1) were also sequenced, using synthetic
oligonucleotides, to complete the sequence of the gene coding
for the second largest subunit. The ORF encoding this subunit,
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Figure 3. Multiple alignment of conserved regions of the largest subunits. Domains
shared with the E.colip' subunit are called A to H as described (34, 50); domain
E is absent in E.coli (SO). Boxes enclose identical amino acids in at least three
out of the four sequences. Numbers on top of the alignment refer to the position
in the multiple alignment, whik numbers at the beginning and end of the sequences
refer to the position in the protein sequence. The Zn-finger (according to (42)),
and the position responsible for amamtin resistence (ama1) in mouse (47) are also
indicated. YEASTL and DR0ME1: largest subunits of S.cerevisiae and
D.melanogastcr RNA polymerase II; WWR1: largest subunit of vaccinia virus
strain WR RNA polymerase.
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Figure 4. Multiple alignment of conserved regions of the second largest subunits.
A to I represent the domains conserved between eukaryotic and E.coli subunits
(36, 37). Residues identical in at least three out of the four sequences are boxed.
Numbering is as in Fig. 3. The active site ((44); the most prcfoaHy labeled amino
acid is marked with an arrow) and the Zn-finger (according to (42)) are indicated.
Abbreviations are as in Fig. 3, with a '21 instead of a * 1 \
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Table L Percent identity and similarity Cm parentheses) between the largest subunhs
according to the multiple alignment.
YEAST1
100
(100)
DROME1
51.0
(67.5)
100
(100)
NP1450L
27.0
(45.5)
26.5
(45.2)
100
(100)
WWR1
20.4
(39.4)
20.4
(41.0)
19.8
(37.5)
100
(100)
YEAST1
DR0ME1
NP1450L
W W R 1
Percentages of identity and similarity were calculated with program DISTANCES
(22), using threshold values of 1.5 and 0.6, respectively.
Table n . Percent identity and similarity (m parentheses) between the second largest
subunits according to the multiple alignment.
DROME2
100
(100)
YEAST2
59.3
(73.6)
100
(100)
EP1242L
29.0
(47.6)
29.0
(46.2)
100
(100)
WWR2
21.0
(38.0)
20.5
(39.7)
18.4
(36.8)
100
(100)
DROME2
YEAST2
EP1242L
WWR2
Percentages of identity and similarity were calculated as described in Table I.
named EP1242L, is 3726 bp-long. The stop codon of this ORF
is included in a set of tandem repeats which also encompasses
the 3' end of a preceding ORF with the opposite transcriptional
orientation (not shown). Protein EP1242L has a deduced
molecular mass of 139.9 kDa, and an isoelectric point of 7.3.
ORFs NP1450L and EP1242L are expressed late in infection
The expression of ORFs NP1450L and EP1242L was analyzed
by RNA hybridization. RNA was obtained from uninfected or
ASFV-infected Vero cells. RNA was also prepared from cells
infected in the presence of either cycloheximide or cytosine
arabinoside, which would allow the detection of RNAs
synthesized in the absence of protein synthesis and DNA
replication, respectively (29).
The probe for NP1450L RNA recognized a specific band of
4.15 kb in the late RNA sample, prepared after the beginning
of DNA replication (Fig. 2). Recent studies on some ASFV
mRNAs suggest that they start a short distance (less than a 100
bp) upstream of the corresponding ORF (30—32), and that they
end at runs of seven or more consecutive thymidylate residues
(7T motif; 30, 31). The distance from the beginning of ORF
NP1450L to the first 7T motif downstream of the ORF is 4.46
kb. We confirmed that the NP1450L RNA has an apparent size
of 4.15 kb by hybridization with a second oligonucleotide probe
(not shown), so we consider that this RNA might have an
anomalous electrophoretic mobility which would cause an
underestimation of its size.
The probe for EP1242L RNA hybridized to a single band of
4.18 kb in late RNA (Fig. 2); a band of the same size could also
be seen in cytosine arabinoside RNA after overexposition of the
film (not shown), indicating a low level of expression of ORF
EP1242L in the absence of DNA replication. The distance from
the beginning of ORF EP1242L to the first 7T motif downstream
of the ORF is 3.94 kb, in rather good agreement with the size
determined for this RNA.
NP1450L and EP1242L are more similar to the eukaryotic
RNA polymerase II subunits than to those of vaccinia virus
FASTA searches in SWISSPROT and NBRF protein databases
with the derived amino acid sequences of NP1450L and EP1242L
gave high scores against the largest and second largest subunits
of eukaryotic, poxviral and bacterial RNA polymerases,
respectively (not shown). Eukaryotic cells have three different
RNA polymerases of similar multimeric structure, whose largest
and second largest subunits share a high amino acid sequence
similarity (reviewed in (33)). Pairwise comparisons of NP1450L
and EP1242L with the largest and second largest subunits of
Saccharomyces cerevisiae RNA polymerases I, II and HI,
respectively, show that the ASFV subunits are more similar to
the equivalent subunits of RNA polymerase II than to those of
RNA polymerases I and HI (not shown). The alignment of the
largest subunit of yeast RNA polymerase II with NP1450L
pointed out the absence of a repetitive C-terminal domain (C-
TD) in the ASFV protein. Lower, but significant, percentages
of identity were obtained when NP1450L and EP1242L were
compared with the equivalent subunits of E.coli RNA
polymerase, /S' and /? (not shown). This is consistent with the
recognized similarity of the two largest RNA polymerase subunits
of eukaryotic and bacterial cells (34-37).
Figs. 3 and 4 show multiple alignments of various regions of
NP1450L and EP1242L with the corresponding subunits of
S. cerevisiae and D.melanogaster RNA polymerase II, and
vaccinia virus RNA polymerase. The domains conserved in the
eukaryotic and E.coli subunits are basically maintained in the
ASFV proteins. The importance of these conserved regions is
heightened by the fact that many different mutations impairing
the function of the yeast enzyme map within them, even though
some others lie outside the conserved domains (38-41). Also
within conserved regions are the Zn-fingers of both subunits ((42),
and refs. therein), already shown to bind Zn (43), and the active
(nucleotide-binding) site of the second largest subunit (44). All
these sites are strictly conserved in the ASFV subunits (Figs.
3 and 4).
The multiple alignments whose fragments are shown in Figs.
3 and 4 allowed us to obtain optimized calculations of the
similarity existing among the yeast, Drosophila, vaccinia virus
and ASFV RNA polymerase subunits. The results, shown in
Tables I and n, demonstrate that the ASFV proteins are more
similar to the eukaryotic RNA polymerase II subunits than to
those of vaccinia virus.
DISCUSSION
The presence in the ASFV genome of genes encoding proteins
similar to the two largest RNA polymerase subunits of poxviruses
and eukaryotic organisms makes it very likely that ASFV
transcription is carried out by a multimeric, virus-encoded, RNA
polymerase. The putative largest subunit of ASFV RNA
polymerase has no repetitive C-terminal domain, thus resembling
the poxviral subunit (2), but its amino acid sequence is more
similar to those of the largest subunits of eukaryotic RNA
polymerases II than to the vaccinia virus subunit. The sequence
of the second largest subunit of ASFV is also more similar to
that of eukaryotic RNA polymerases n. Moreover, ASFV and
vaccinia virus RNA polymerases might have a slightly different
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subunit composition, because ASFV encodes a protein similar
to the sixth subunit of yeast RNA polymerase II (RPB6;
J.M.Rodriguez, R.J.Y., J.F.Rodriguez and E.V., unpublished),
while no similar protein is encoded in the genome of vaccinia
virus. Taken together, all these data suggest that ASFV RNA
polymerase could be more similar to the eukaryotic RNA
polymerase JJ than to the poxviral enzyme, both in subunit
composition and in the amino acid sequences of the individual
sutfunits. The mechanism of action of the ASFV protein similar
to the eukaryotic TFJJS and to the vaccinia virus protein rpo30
could shed light on this matter, considering that the eukaryotic
protein is an RNA polymerase-associated transcription factor,
while rpo30 is considered a true enzyme subunit due to its tight
association to the viral enzyme (10).
The eukaryotic RNA polymerase II is very sensitive to
a-amanitin (reviewed in (8)), an inhibitor of RNA elongation
(45, 46). The mutation responsible for a-amanitin resistence in
a BALB/c 3T3 mouse cell line is an Asn to Asp change at position
793 in the largest subunit (47). This Asn residue is highly
conserved in RNA polymerases II (see the multiple alignment
in (48)). In fact, as has previously been noticed (47, 48), the
changes at that position of RNA polymerase U correlate very
well with the partial or complete resistence to a-amanitin of the
enzyme from S.cerevisiae (49), S.pombe (48), vaccinia virus (1)
and ASFV (7), which have Ser, He, Arg and Glu, respectively,
at the corresponding position ((47, 48); see also Fig.3).
The genes encoding the putative two largest subunits of ASFV
RNA polymerase are mainly expressed late in the virus infectious
cycle, after replication of viral DNA has begun. This fact implies
that most, if not all, the ASFV RNA polymerase activity present
in the infected cell at the early stage was carried by the infecting
virus particle(s) (7). On the other hand, the RNA polymerase
molecules synthesized during the late phase are probably
responsible of further transcription of late genes, and are finally
incorporated into ASFV particles.
In summary, we have identified two ORFs which encode RNA
polymerase subunits with considerable similarity to their cellular
counterparts. The capacity of ASFV to encode such proteins
suggests that ASFV transcription is carried out by a multimeric
enzyme whose subunits are encoded in the viral genome. Studies
to characterize the RNA polymerase of ASFV and identify
additional subunits are underway.
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